Core Warming of Coronavirus Disease 2019 Patients Undergoing Mechanical Ventilation: A Pilot Study
MD Nathaniel P Bonfanti, MD, MS Nicholas M Mohr, MD David C Willms, MD, MS Roger J Bedimo, MD Emily Gundert, MD Kristina L Goff, MD Erik B Kulstad, MD Anne M Drewry
Therapeutic Hypothermia and Temperature Management, doi:10.1089/ther.2023.0030
Fever is a recognized protective factor in patients with sepsis, and growing data suggest beneficial effects on outcomes in sepsis with elevated temperature, with a recent pilot randomized controlled trial (RCT) showing lower mortality by warming afebrile sepsis patients in the intensive care unit (ICU). The objective of this prospective single-site RCT was to determine if core warming improves respiratory physiology of mechanically ventilated patients with coronavirus disease 2019 (COVID-19), allowing earlier weaning from ventilation, and greater overall survival. A total of 19 patients with mean age of 60.5 (-12.5) years, 37% female, mean weight 95.1 (-18.6) kg, and mean body mass index 34.5 (-5.9) kg/m 2 with COVID-19 requiring mechanical ventilation were enrolled from September 2020 to February 2022. Patients were randomized 1:1 to standard of care or to receive core warming for 72 hours through an esophageal heat exchanger commonly utilized in critical care and surgical patients. The maximum target temperature was 39.8°C. A total of 10 patients received usual care and 9 patients received esophageal core warming. After 72 hours of warming, the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) ratios were 197 (-32) and 134 (-13.4), cycle thresholds were 30.8 (-6.4) and 31.4 (-3.2), ICU mortalities were 40% and 44%, 30-day mortalities were 30% and 22%, and mean 30-day ventilator-free days were 11.9 (-12.6) and 6.8 (-10.2) for standard of care and warmed patients, respectively ( p = NS). This pilot study suggests that core warming of patients with COVID-19 undergoing mechanical ventilation is feasible and appears safe. Optimizing time to achieve febrile-range temperature may require a multimodal temperature management strategy to further evaluate effects on outcome. ClinicalTrials.
Authors' Contributions Writing-original draft, review, and editing by N.P.B. Methodology, data curation, and formal analysis by N.M.M.
References
Anderson, Joseph, Fisher, Targeted temperature management using esophageal cooling, Ther Hypothermia Temp Manag,
doi:10.1089/ther.2022.0033
Bonfanti, Gundert, Drewry, Core warming of coronavirus disease 2019 (COVID-19) patients undergoing mechanical ventilation-A protocol for a randomized controlled pilot study, PLoS One,
doi:10.1371/journal.pone.0243190
Bonfanti, None
Chan, Peiris, Lam, The effects of temperature and relative humidity on the viability of the SARS coronavirus, Adv Virol,
doi:10.1155/2011/734690
Dallimore, Ebmeier, Thayabaran, Effect of active temperature management on mortality in intensive care unit patients, Crit Care Resusc
Drewry, Ablordeppey, Murray, Antipyretic therapy in critically ill septic patients: A systematic review and meta-analysis, Crit Care Med,
doi:10.1097/CCM.0000000000002285
Drewry, Ablordeppey, Murray, Monocyte function and clinical outcomes in febrile and afebrile patients with severe sepsis, Shock,
doi:10.1097/SHK.0000000000001083
Drewry, Hotchkiss, Counterpoint: Should antipyretic therapy be given routinely to febrile patients in septic shock? No, Chest,
doi:10.1378/chest.13-0918
Drewry, Mohr, Ablordeppey, Therapeutic hyperthermia is associated with improved survival in afebrile critically ill patients with sepsis: A pilot randomized trial, Crit Care Med,
doi:10.1097/ccm.0000000000005470
Evans, Repasky, Fisher, Fever and the thermal regulation of immunity: The immune system feels the heat, Nat Rev Immunol,
doi:10.1038/nri3843
Foxman, Storer, Fitzgerald, Temperaturedependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells, Proc Natl Acad Sci,
doi:10.1073/pnas.1411030112
Furrer, Garcia, Pfister, Perioperative targeted temperature management of severely burned patients by means of an oesophageal temperature probe, Burns,
doi:10.1016/j.burns.2022.03.015
Gozzoli, Schottker, Suter, Is it worth treating fever in intensive care unit patients? Preliminary results from 228 BONFANTI ET AL. a randomized trial of the effect of external cooling, Arch Intern Med,
doi:10.1001/archinte.161.1.121
Itenov, Johansen, Bestle, Induced hypothermia in patients with septic shock and respiratory failure (CASS): A randomised, controlled, open-label trial, Lancet Respir Med,
doi:10.1016/s2213-2600(18)30004-3
Kwei-Nsoro, Attar, Shaka, Independent predictors and causes of thirty-day gastrointestinal readmissions following COVID-19-related hospitalizations: Analysis of the National Readmission Database, Gastroenterol Res,
doi:10.14740/gr1623
Laporte, Stevaert, Raeymaekers, Hemagglutinin cleavability, acid stability, and temperature dependence optimize influenza B virus for replication in human airways, J Virol,
doi:10.1128/jvi.01430-19
Launey, Nesseler, Malle ´dant, Clinical review: Fever in septic ICU patients-Friend or foe?, Crit Care,
doi:10.1186/cc10097
Lee, Zhong, Mace, Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge, PLoS One,
doi:10.1371/journal.pone.0030077
Leung, Toor, Akhtar, Real-world results of oesophageal protection from a temperature control device during left atrial ablation, Europace,
doi:10.1093/europace/euad099
Peters, Woolfall, Khan, Permissive versus restrictive temperature thresholds in critically ill children with fever and infection: A multicentre randomized clinical pilot trial, Crit Care,
doi:10.1186/s13054-019-2354-4
Ping, Rapid response to: Graphic Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: Case report, BMJ
Roger, COVID-19: Should we consider it as a septic shock? (The treatment of COVID-19 patients in the ICU), Curr Opin Anaesthesiol,
doi:10.1097/aco.0000000000000956
Rumbus, Matics, Hegyi, Fever is associated with reduced, hypothermia with increased mortality in septic patients: A meta-analysis of clinical trials, PLoS One,
doi:10.1371/journal.pone.0170152
Saoraya, Musikatavorn, Puttaphaisan, Intensive fever control using a therapeutic normothermia protocol in patients with febrile early septic shock: A randomized feasibility trial and exploration of the immunomodulatory effects, SAGE Open Med,
doi:10.1177/2050312120928732
Schulman, Namias, Doherty, The effect of antipyretic therapy upon outcomes in critically ill patients: A randomized, prospective study, Surg Infect (Larchmt),
doi:10.1089/sur.2005.6.369
Stanley, Jackson, Panusarn, Increased virus shedding with aspirin treatment of rhinovirus infection, JAMA
Young, Bellomo, Bernard, Fever control in critically ill adults. An individual patient data meta-analysis of randomised controlled trials, Intensive Care Med,
doi:10.1007/s00134-019-05553-w
Young, Saxena, Bellomo, Acetaminophen for fever in critically ill patients with suspected infection, N Engl J Med,
doi:10.1056/NEJMoa1508375
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study, Lancet,
doi:10.1016/S0140-6736(20)30566-3
Zou, Ruan, Huang, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med,
doi:10.1056/NEJMc2001737